HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.

Abstract
The frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae obtained in Tokyo in 2002 was studied. The frequencies of GyrA and ParC mutations in these 19 isolates were 100% (19 of 19) and 84.2% (16 of 19), respectively, and these results were 1.48-fold (100%/67.6%) and 3.58-fold (84.2%/23.5%) higher, respectively, than the frequencies reported in 1998 in 68 isolates obtained in Fukuoka during the period from 1992 to 1996. Isolates with increasing numbers of mutations were more resistant not only to levofloxacin but also to other antibiotics. The 50% and 90% minimum inhibitory concentrations (MICs) to levofloxacin during the period from 1995 to 1996 were 0.063 and 1 micro g/ml, and they increased to 4 and 8 micro g/ml, respectively, in the present study. All 19 cases of gonoccocal urethritis in the present study were cured with a single intramuscular injection of 2 g spectinomycin.
AuthorsHiroyuki Abe, Taiji Nishimura, Yoshihiko Norose, Taiji Aoto, Hiroki Ohzuka, Hisashi Ohkuni
JournalJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother) Vol. 9 Issue 4 Pg. 310-3 (Dec 2003) ISSN: 1341-321X [Print] Netherlands
PMID14691651 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Levofloxacin
  • Spectinomycin
  • Ofloxacin
  • DNA Topoisomerase IV
  • DNA Gyrase
Topics
  • Anti-Bacterial Agents (pharmacology)
  • DNA Gyrase (chemistry, genetics)
  • DNA Topoisomerase IV (genetics)
  • Drug Resistance, Bacterial
  • Gonorrhea (drug therapy, microbiology)
  • Humans
  • Levofloxacin
  • Male
  • Microbial Sensitivity Tests
  • Mutation
  • Neisseria gonorrhoeae (drug effects, enzymology, genetics)
  • Ofloxacin (pharmacology)
  • Prevalence
  • Spectinomycin (therapeutic use)
  • Tokyo (epidemiology)
  • Urethritis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: